Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Lotus Ventures Inc. is a Canadian-based company focused on the production and distribution of cannabis products, specifically targeting the medical market. Its competitive position is bolstered by its cultivation facilities in British Columbia and a growing product line that includes oils and edibles, catering to a niche market of medical cannabis users.
Lotus Ventures generates revenue primarily through the sale of cannabis products, leveraging its cultivation facilities to maintain quality and control over production. The company has established partnerships with healthcare providers to enhance its market reach and pricing power, particularly in the medical cannabis sector.
Changes in Canadian cannabis regulations affecting market access
Fluctuations in wholesale cannabis prices
Expansion of distribution agreements with healthcare providers
Consumer demand shifts in the medical cannabis market
Regulatory changes that could impact market access or operational costs
Technological disruption in cannabis cultivation methods
Increasing competition from larger cannabis producers with more resources
Potential market saturation in the medical cannabis segment
Negative cash flow and high free cash flow yield of -132.1% indicating liquidity challenges
Operating margins at -79.6% raise concerns about long-term sustainability
moderate - The cannabis industry is somewhat insulated from economic downturns due to its focus on medical applications, but overall consumer spending trends can impact sales.
Interest rates affect financing costs for expansion and operational investments, which can impact profitability and valuation multiples.
minimal - The company has a manageable debt-to-equity ratio of 0.27, indicating low reliance on external financing.
growth - Investors looking for exposure to the expanding cannabis market, particularly in medical applications.
high - The stock has shown significant price volatility, with a one-year return of -75.0%.
